Compile Data Set for Download or QSAR
maximum 50k data
Found 23 with Last Name = 'artman, iii' and Initial = 'gd'
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM50030474(Avandamet | Avandaryl | Avandia | BRL-49653 | CHEB...)
Affinity DataIC50:  125nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228151((2s)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethox...)
Affinity DataIC50:  3.70E+3nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228140((2s)-2-ethoxy-n-methoxy-3-{4-[(4-methoxypyridin-2-...)
Affinity DataIC50:  7.90E+3nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228150(US9562012, 20 | ethyl (2s)-2-ethoxy-3-{4-[2-(3-met...)
Affinity DataIC50:  1.09E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228137((2s)-2-ethoxy-3-{4-[(4-methoxypyridin-2-yl)methoxy...)
Affinity DataIC50:  1.18E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228129(US9562012, mitoglitazone)
Affinity DataIC50:  2.66E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228147(US9562012, 17 | ethyl (2r)-2-ethoxy-3-{4-[(2s)-2-h...)
Affinity DataIC50:  2.77E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228134(US9562012, 4 | ethyl (2s)-2-ethoxy-3-[4-(pyridin-2...)
Affinity DataIC50:  2.77E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228141((2s)-2-ethoxy-n-hydroxy-3-{4-[(4-methoxypyridin-2-...)
Affinity DataIC50:  3.05E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228131(US9562012, 1 | ethyl (2s)-2-ethoxy-3-(4-hydroxyphe...)
Affinity DataIC50:  5.89E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228143((2r)-2-ethoxy-3-{4-[2-(3-methoxyphenyl)-2-oxoethox...)
Affinity DataIC50:  6.14E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228138((2s)-2-ethoxy-n-hydroxy-3-{4-[(4-methoxypyridin-2-...)
Affinity DataIC50:  9.85E+4nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228132(US9562012, 2 | ethyl (2r)-2-ethoxy-3-(4-hydroxyphe...)
Affinity DataIC50: >1.00E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228142(US9562012, 12 | ethyl (2r)-2-ethoxy-3-{4-[2-(3-met...)
Affinity DataIC50:  1.64E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228146((2r)-2-ethoxy-3-{4-[(2s)-2-hydroxy-2-(3-methoxyphe...)
Affinity DataIC50:  1.91E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228136(US9562012, 6 | ethyl (2s)-2-ethoxy-3-{4-[(4-methox...)
Affinity DataIC50: >1.95E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228145((2r)-2-ethoxy-n-methoxy-3-{4-[2-(3-methoxyphenyl)-...)
Affinity DataIC50: >2.00E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228149((2r)-2-ethoxy-3-{4-[(2r)-2-hydroxy-2-(3-methoxyphe...)
Affinity DataIC50: >2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228148((2r)-2-ethoxy-n-hydroxy-3-{4-[(2s)-2-hydroxy-2-(3-...)
Affinity DataIC50: >2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228133((2s)-2-ethoxy-n-hydroxy-3-{4-[(3-iodobenzyl)oxy]ph...)
Affinity DataIC50: >2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228135((2s)-2-ethoxy-n-hydroxy-3-[4-(pyridin-2-ylmethoxy)...)
Affinity DataIC50: >2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228139((2s)-2-ethoxy-n-methoxy-3-{4-[(4-methoxypyridin-2-...)
Affinity DataIC50: >2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNuclear receptor coactivator 2 [740-753]()
Metabolic Solutions Development

US Patent
LigandPNGBDBM228144((2r)-2-ethoxy-n-methoxy-3-{4-[2-(3-methoxyphenyl)-...)
Affinity DataIC50: >2.50E+5nMAssay Description:PPARγ binding is measured by a TR-FRET competitive binding assay using Invitrogen LanthaScreen TR-FRET PPARγ Competitive Binding Assay (I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent